Tracing the alterations of proinflammatory biomarkers, such as IL-1β, IL-6, IL-10, TNF-α, RANTES, and hsCRP, in the CSF or blood can aid in the early diagnosis of PD and monitoring of disease progression. This evidence concerns the gene CCL5 and Parkinson disease.